Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Longo

Showing results (291-300 of 484) with videos related to

Pageof 49
Sort By:
Annals of Internal Medicine|March 1, 1987
NIH conference. Immunomodulators in clinical medicineA S Fauci, S A Rosenberg, S A Sherwin, et al.
Analytical Biochemistry|February 15, 1987
Generation of a murine monoclonal antibody that detects the fos oncogene productS L Giardina, S W Evans, L Gandino, et al.
Journal of the National Cancer Institute|November 20, 1991
Kinetics of recovery of CD4+ T cells in peripheral blood of deoxycoformycin-treated patientsR G Steis, W J Urba, W C Kopp, et al.
Cancer|May 15, 1990
Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapyK C Conlon, W J Urba, J W Smith, et al.
Cancer Research|September 1, 1985
Lymph node pathology of HTLV and HTLV-associated neoplasmsE S Jaffe, J Clark, R Steis, et al.
Blood|May 1, 1988
Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemiaR G Steis, L Marcon, J Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunityH I Levitsky, J Montgomery, M Ahmadzadeh, et al.
Blood|June 1, 1994
Inhibitory cytokine circuits involving transforming growth factor-beta, interferon-gamma, and interleukin-2 in human monocyte activationI Espinoza-Delgado, M C Bosco, T Musso, et al.
International Immunology|May 1, 1997
Sequence changes at the V-D junction of the VH1 heavy chain of anti-phosphocholine antibodies alter binding to and protection against Streptococcus pneumoniaeW X Guo, A M Burger, R T Fischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 1991
The calculation of actual or received dose intensity: a comparison of published methodsD L Longo, P L Duffey, V T DeVita, et al.
Pageof 49

Showing results (291-300 of 484) with videos related to

Sort By:
Pageof 49
Annals of Internal Medicine|March 1, 1987
NIH conference. Immunomodulators in clinical medicineA S Fauci, S A Rosenberg, S A Sherwin, et al.
Analytical Biochemistry|February 15, 1987
Generation of a murine monoclonal antibody that detects the fos oncogene productS L Giardina, S W Evans, L Gandino, et al.
Journal of the National Cancer Institute|November 20, 1991
Kinetics of recovery of CD4+ T cells in peripheral blood of deoxycoformycin-treated patientsR G Steis, W J Urba, W C Kopp, et al.
Cancer|May 15, 1990
Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapyK C Conlon, W J Urba, J W Smith, et al.
Cancer Research|September 1, 1985
Lymph node pathology of HTLV and HTLV-associated neoplasmsE S Jaffe, J Clark, R Steis, et al.
Blood|May 1, 1988
Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemiaR G Steis, L Marcon, J Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunityH I Levitsky, J Montgomery, M Ahmadzadeh, et al.
Blood|June 1, 1994
Inhibitory cytokine circuits involving transforming growth factor-beta, interferon-gamma, and interleukin-2 in human monocyte activationI Espinoza-Delgado, M C Bosco, T Musso, et al.
International Immunology|May 1, 1997
Sequence changes at the V-D junction of the VH1 heavy chain of anti-phosphocholine antibodies alter binding to and protection against Streptococcus pneumoniaeW X Guo, A M Burger, R T Fischer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 1991
The calculation of actual or received dose intensity: a comparison of published methodsD L Longo, P L Duffey, V T DeVita, et al.
Pageof 49